POLYMED

Poly Medicure Shareholding Pattern

₹1,625.00-0.54%
Market cap
₹16,471 crore
P/E
52.5
P/B
5.30
ROE
11.3%
Dividend yield
0.22%

As of 30-JUN-2026, promoters held 62.42% of Poly Medicure (0.00 pp from 31-MAR-2026), foreign institutional investors 5.57%, domestic institutions 16.08% and the public 15.94%.

Poly Medicure shareholding pattern

Percentage of shares held, by quarter, newest first.

Poly Medicure shareholding by category (% of equity)
Holder30-JUN-202631-MAR-202631-DEC-202530-SEP-202530-JUN-202531-MAR-2025Change
Promoters62.42%62.42%62.42%62.42%62.44%n/a0.00 pp
Foreign institutions (FII/FPI)5.57%5.91%9.40%9.77%11.41%n/a-0.34 pp
Domestic institutions (DII)16.08%15.59%13.84%13.54%11.72%n/a+0.49 pp
Public15.94%16.08%14.34%14.27%14.44%n/a-0.14 pp

Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.

Poly Medicure shareholding pattern — frequently asked questions

What is the promoter holding in Poly Medicure?

Promoters held 62.42% of Poly Medicure as of 30-JUN-2026, unchanged from 62.42% in 31-MAR-2026.

How much do FIIs hold in Poly Medicure?

Foreign institutional investors held 5.57% of Poly Medicure as of 30-JUN-2026, a change of -0.34 pp from the previous quarter.

How much do domestic institutions hold in Poly Medicure?

Domestic institutional investors, including mutual funds and insurers, held 16.08% of Poly Medicure as of 30-JUN-2026 (+0.49 pp from the previous quarter).

Who owns Poly Medicure?

As of 30-JUN-2026, Poly Medicure's shareholders were promoters (62.42%), foreign institutional investors 5.57%, domestic institutions 16.08% and the public 15.94%, as filed with the stock exchanges.

Same Data For Peers

Trade Poly Medicure With ATS

Track POLYMED live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.